MedPath

BTG International Inc.

BTG International Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

12

Active:0
Completed:8

Trial Phases

3 Phases

Phase 1:2
Phase 2:5
Phase 4:1

Drug Approvals

2

FDA:2

Drug Approvals

Cyanokit

Approval Date
Apr 27, 2023
FDA

Voraxaze

Approval Date
Nov 18, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 2
5 (62.5%)
Phase 1
2 (25.0%)
Phase 4
1 (12.5%)

A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.

Completed
Conditions
Breast Cancer
First Posted Date
2023-09-06
Last Posted Date
2024-05-10
Lead Sponsor
BTG International Inc.
Target Recruit Count
101
Registration Number
NCT06024213
Locations
🇫🇷

CH Annecy-Genevois, Annecy, Epagny Metz-Tessy, Haute-Savoie, France

🇫🇷

Institut Bergonié, Bordeaux, Gironde, France

🇫🇷

CHU de Saint-Etienne, Saint-Etienne, Loire, France

and more 3 locations

Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation

Phase 4
Completed
Conditions
Snake Bites
First Posted Date
2013-05-29
Last Posted Date
2017-11-22
Lead Sponsor
BTG International Inc.
Target Recruit Count
74
Registration Number
NCT01864200
Locations
🇺🇸

Georgia Regents University, Augusta, Georgia, United States

🇺🇸

University of Kansas Hospital, Kansas City, Kansas, United States

🇺🇸

Washington University, Saint Louis, Missouri, United States

and more 15 locations

Copperhead Envenomation Observational Study

Completed
Conditions
Copperhead Snake Envenomation
First Posted Date
2012-07-27
Last Posted Date
2013-05-13
Lead Sponsor
BTG International Inc.
Target Recruit Count
20
Registration Number
NCT01651299
Locations
🇺🇸

University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States

🇺🇸

LSU Health Sciences Center, Shreveport, Louisiana, United States

🇺🇸

University of Mississippi Medical Center, Jackson, Michigan, United States

and more 8 locations

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

Phase 1
Completed
Conditions
Vaccine
First Posted Date
2009-11-18
Last Posted Date
2014-09-15
Lead Sponsor
BTG International Inc.
Target Recruit Count
50
Registration Number
NCT01015703
Locations
🇬🇧

Quintiles Drug Research Unit, London, United Kingdom

Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation

Completed
Conditions
Snake Envenomation
First Posted Date
2009-06-25
Last Posted Date
2022-06-28
Lead Sponsor
BTG International Inc.
Target Recruit Count
247
Registration Number
NCT00927381
Locations
🇺🇸

Rocky Mountain Poison and Drug Center, Denver, Colorado, United States

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.